Abstract

Objective: In this subanalysis of the prospective randomized multicenter SENTICOL 2 study, we compared the quality of life (QoL), in two arms, in association with lower-limb consequences in women with early stage cervical cancer undergoing randomized sentinel lymph node (SLN) sampling alone or SLN sampling and full pelvic lymphadenectomy.Methods: 206 patients with an early stage cervical cancer and a negative SLN, were randomized. Every patient had a SLN detection based on a combination of radio-isotope (Nanocis®) and blue dye (Bleu Patenté®) injections. One hundred and One patients, the “standard” group, had complete pelvic lymphadenectomy, 105 patients, the “SLN alone” group, had SLN biopsy without lymphadenectomy. At each visit (V0: preoperative, V1: 1 month, V2: 3 months and V3: 6 months following surgery) the patients completed a Short Form Health Survey (SF36) questionnaire and another questionnaire related to leg lymphedema. SF36 scores variations (compared to the baseline values) were assessed with a standard analysis and by an evaluation of the area under the curve (AUC). Several lower-limb circumferences and signs were also determined.Results: General characteristics of the patients were well–balanced between groups. Physical function and general health dimensions of the SF36 scale were significantly improved at V1 and V2 in the “SLN alone” group. Mental health was also statistically better in the “SLN alone” group at V2. Other dimensions were similar. The two groups had similar evaluation at V3. AUC of SF36 sub-scores was also in favor of the “SLN alone” arm, but the difference was not statistically significant. The analysis about the lymphedema of the legs showed a reduced (but not significant) risk in the “SLN alone” group for the top-of-thigh and the mid-thigh perimeters. Lymphedema symptoms reported by the patients were significantly less severe in the “SLN alone” group.Conclusion: Our study demonstrates a trend for a better quality of life and less severe leg heaviness and leg fatigue when a full pelvic lymphadenectomy is avoided.

Highlights

  • For two decades, the sentinel lymph node (SLN) technique has been validated by many studies and is, currently, an integral part in the management of melanoma, breast cancer, and vulvar cancer

  • SF36 sub-scores at the inclusion visit (V0) were similar for the two groups, except for the General Health which showed a significantly better score in the “SLN alone” group

  • The major objective of the study was the evaluation of short term (30 days postsurgery) and medium term (6 months post-surgery) morbidity of the SLN resection alone in comparison to a complete pelvic lymphadenectomy

Read more

Summary

Introduction

The sentinel lymph node (SLN) technique has been validated by many studies and is, currently, an integral part in the management of melanoma, breast cancer, and vulvar cancer. This technique was first used in cervical cancer ∼15 years ago [1]. The surgical treatment of early stage cervical cancer is based on a radical hysterectomy or a radical trachelectomy associated to pelvic lymphadenectomy. According to the actual ESGO [10] and National Comprehensive Cancer Network [11] guidelines a negative SLN does not allow renunciation of a pelvic radical lymph node dissection [12]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call